We also re-analyzed a published cDNA microarray dataset generated from prostate cancer tissues as described previously [27, 28] and identified a clear association of DPYSL3 gene reduction along with disease progression from primary cancer to castration-resistant metastatic cancers (Figure 1B). Here, DPYSL3 is linked to prostate cancer.